Cargando…
Design and Synthesis of Brain Penetrant Glycopeptide Analogues of PACAP With Neuroprotective Potential for Traumatic Brain Injury and Parkinsonism
There is an unmet clinical need for curative therapies to treat neurodegenerative disorders. Most mainstay treatments currently on the market only alleviate specific symptoms and do not reverse disease progression. The Pituitary adenylate cyclase-activating polypeptide (PACAP), an endogenous neurope...
Autores principales: | Apostol, Christopher R., Bernard, Kelsey, Tanguturi, Parthasaradhireddy, Molnar, Gabriella, Bartlett, Mitchell J., Szabò, Lajos, Liu, Chenxi, Ortiz, J. Bryce, Saber, Maha, Giordano, Katherine R., Green, Tabitha R. F., Melvin, James, Morrison, Helena W., Madhavan, Lalitha, Rowe, Rachel K., Streicher, John M., Heien, Michael L., Falk, Torsten, Polt, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887546/ https://www.ncbi.nlm.nih.gov/pubmed/35237767 http://dx.doi.org/10.3389/fddsv.2021.818003 |
Ejemplares similares
-
Synthesis and In Vitro Characterization of Glycopeptide Drug Candidates Related to PACAP(1–23)
por: Apostol, Christopher R., et al.
Publicado: (2021) -
The role of opioid receptors in modulating Alzheimer’s Disease
por: Tanguturi, Parthasaradhireddy, et al.
Publicado: (2023) -
The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia
por: Bartlett, Mitchell J., et al.
Publicado: (2020) -
CNS active O-linked glycopeptides
por: Jones, Evan M., et al.
Publicado: (2015) -
Discovery of PACAP and its receptors in the brain
por: Hirabayashi, Takahiro, et al.
Publicado: (2018)